These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9367357)

  • 41. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demonstration of binding of dengue virus envelope protein to target cells.
    Chen Y; Maguire T; Marks RM
    J Virol; 1996 Dec; 70(12):8765-72. PubMed ID: 8971005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates.
    Chen HW; Liu SJ; Li YS; Liu HH; Tsai JP; Chiang CY; Chen MY; Hwang CS; Huang CC; Hu HM; Chung HH; Wu SH; Chong P; Leng CH; Pan CH
    Arch Virol; 2013 Jul; 158(7):1523-31. PubMed ID: 23456422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins.
    Tsai WY; Hsieh SC; Lai CY; Lin HE; Nerurkar VR; Wang WK
    PLoS One; 2012; 7(12):e52600. PubMed ID: 23300717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.
    Kaushik N; Rohila D; Arora U; Raut R; Lamminmäki U; Khanna N; Batra G
    BMC Biotechnol; 2016 Feb; 16():12. PubMed ID: 26847361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice.
    Staropoli I; Frenkiel MP; Mégret F; Deubel V
    Vaccine; 1997 Dec; 15(17-18):1946-54. PubMed ID: 9413106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A ligand-binding pocket in the dengue virus envelope glycoprotein.
    Modis Y; Ogata S; Clements D; Harrison SC
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):6986-91. PubMed ID: 12759475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virus-specific read-through codon preference affects infectivity of chimeric cucumber green mottle mosaic viruses displaying a dengue virus epitope.
    Teoh PG; Ooi AS; AbuBakar S; Othman RY
    J Biomed Biotechnol; 2009; 2009():781712. PubMed ID: 19325913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced prokaryotic expression of dengue virus envelope protein.
    Ganguly A; Malabadi RB; Das D; Suresh MR; Sunwoo HH
    J Pharm Pharm Sci; 2013; 16(4):609-21. PubMed ID: 24210067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera.
    Barros MC; Galasso TG; Chaib AJ; Degallier N; Nagata T; Ribeiro BM
    Virol J; 2011 May; 8():261. PubMed ID: 21619598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.
    Slon Campos JL; Marchese S; Rana J; Mossenta M; Poggianella M; Bestagno M; Burrone OR
    Sci Rep; 2017 Apr; 7(1):966. PubMed ID: 28424472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In situ removal of consensus dengue virus envelope protein domain III fused to hydrophobin in Pichia pastoris cultures.
    Cerezo J; Smith ME; Rodríguez Talou J
    Protein Expr Purif; 2019 Jan; 153():131-137. PubMed ID: 30240632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli.
    Chiu MW; Yang YL
    Biochem Biophys Res Commun; 2003 Sep; 309(3):672-8. PubMed ID: 12963043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs.
    Zulueta A; Hermida L; Lazo L; Valdés I; Rodríguez R; López C; Silva R; Rosario D; Martín J; Guzmán MG; Guillén G
    Biochem Biophys Res Commun; 2003 Aug; 308(3):619-26. PubMed ID: 12914796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.
    Kim TG; Kim MY; Huy NX; Kim SH; Yang MS
    Mol Biotechnol; 2013 Jul; 54(3):880-7. PubMed ID: 23250723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptor-activated human α2-macroglobulin interacts with the envelope protein of dengue virus and protects virions from temperature-induced inactivation through multivalent binding.
    Huerta V; Toledo P; Fleitas N; Martín A; Pupo D; Yero A; Sarría M; Sánchez A; Besada V; Ramos Y; Márquez G; Guirola O; Chinea G
    J Gen Virol; 2014 Dec; 95(Pt 12):2668-2676. PubMed ID: 25100798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions.
    Zheng A; Umashankar M; Kielian M
    PLoS Pathog; 2010 Oct; 6(10):e1001157. PubMed ID: 20975939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.